Heather Preston - Net Worth and Insider Trading
Heather Preston Net Worth
The estimated net worth of Heather Preston is at least $29 Million dollars as of 2024-11-13. Heather Preston is the Director of Akouos Inc and owns about 1,799,970 shares of Akouos Inc (AKUS) stock worth over $24 Million. Heather Preston is the Director, 10% Owner of Entasis Therapeutics Holdings Inc and owns about 1,180,178 shares of Entasis Therapeutics Holdings Inc (ETTX) stock worth over $3 Million. Heather Preston is also the Director of Karuna Therapeutics Inc and owns about 5,800 shares of Karuna Therapeutics Inc (KRTX) stock worth over $2 Million. Besides these, Heather Preston also holds Fusion Pharmaceuticals Inc (FUSN) . Details can be seen in Heather Preston's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Heather Preston has not made any transactions after 2020-09-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Heather Preston
Heather Preston Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Heather Preston owns 7 companies in total, including Karuna Therapeutics Inc (KRTX) , Akouos Inc (AKUS) , and Fusion Pharmaceuticals Inc (FUSN) among others .
Click here to see the complete history of Heather Preston’s form 4 insider trades.
Insider Ownership Summary of Heather Preston
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KRTX | Karuna Therapeutics Inc | 2020-09-04 | director |
| AKUS | Akouos Inc | 2020-06-30 | director & 10 percent owner |
| FUSN | Fusion Pharmaceuticals Inc | 2020-06-30 | director |
 | | 2019-10-22 | director |
| | 2019-06-19 | director |
| | 2014-08-12 | director |
| | 2016-11-03 | director |
Heather Preston Latest Holdings Summary
Heather Preston currently owns a total of 4 stocks. Among these stocks, Heather Preston owns 1,799,970 shares of Akouos Inc (AKUS) as of June 30, 2020, with a value of $24 Million and a weighting of 83.61%. Heather Preston owns 1,180,178 shares of Entasis Therapeutics Holdings Inc (ETTX) as of September 28, 2018, with a value of $3 Million and a weighting of 9.03%. Heather Preston also owns 5,800 shares of Karuna Therapeutics Inc (KRTX) as of September 4, 2020, with a value of $2 Million and a weighting of 6.69%. The other 1 stocks Fusion Pharmaceuticals Inc (FUSN) have a combined weighting of 0.66% among all his current holdings.
Latest Holdings of Heather Preston
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AKUS | Akouos Inc | 2020-06-30 | 1,799,970 | 13.29 | 23,921,601 |
| ETTX | Entasis Therapeutics Holdings Inc | 2018-09-28 | 1,180,178 | 2.19 | 2,584,590 |
| KRTX | Karuna Therapeutics Inc | 2020-09-04 | 5,800 | 329.83 | 1,913,014 |
| FUSN | Fusion Pharmaceuticals Inc | 2020-06-30 | 8,823 | 21.55 | 190,136 |
Holding Weightings of Heather Preston
Heather Preston Form 4 Trading Tracker
According to the SEC Form 4 filings, Heather Preston has made a total of 1 transactions in Akouos Inc (AKUS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Akouos Inc is the acquisition of 299,999 shares on June 30, 2020, which cost Heather Preston around $5 Million.
According to the SEC Form 4 filings, Heather Preston has made a total of 0 transactions in Entasis Therapeutics Holdings Inc (ETTX) over the past 5 years. The most-recent trade in Entasis Therapeutics Holdings Inc is the acquisition of 337,724 shares on September 28, 2018, which cost Heather Preston around $5 Million.
According to the SEC Form 4 filings, Heather Preston has made a total of 5 transactions in Karuna Therapeutics Inc (KRTX) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in Karuna Therapeutics Inc is the acquisition of 350 shares on September 4, 2020, which cost Heather Preston around $25,326.
More details on Heather Preston's insider transactions can be found in the Insider Trading History of Heather Preston table.Insider Trading History of Heather Preston
- 1
Heather Preston Trading Performance
GuruFocus tracks the stock performance after each of Heather Preston's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Heather Preston is -4.8%. GuruFocus also compares Heather Preston's trading performance to market benchmark return within the same time period. The performance of stocks bought by Heather Preston within 3 months outperforms 5 times out of 8 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Heather Preston's insider trading performs compared to the benchmark.
Performance of Heather Preston
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.36 | | | | | |
| Relative Return to S&P 500(%) | -0.23 | | | | | |
Heather Preston Ownership Network
Ownership Network List of Heather Preston
Ownership Network Relation of Heather Preston
Heather Preston Owned Company Details
What does Karuna Therapeutics Inc do?
Who are the key executives at Karuna Therapeutics Inc?
Heather Preston is the director of Karuna Therapeutics Inc. Other key executives at Karuna Therapeutics Inc include Chief Medical Officer Stephen K. Brannan , Chief Financial Officer Jason Parker Brown , and Chief Financial Officer Troy A. Ignelzi .
Karuna Therapeutics Inc (KRTX) Insider Trades Summary
Over the past 18 months, Heather Preston made no insider transaction in Karuna Therapeutics Inc (KRTX). Other recent insider transactions involving Karuna Therapeutics Inc (KRTX) include a net sale of 55,000 shares made by Stephen K. Brannan , a net sale of 41,429 shares made by Jeffrey M Jonas , and a net sale of 10,500 shares made by Troy A. Ignelzi .
In summary, during the past 3 months, insiders sold 0 shares of Karuna Therapeutics Inc (KRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 106,929 shares of Karuna Therapeutics Inc (KRTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 106,929 shares.
Karuna Therapeutics Inc (KRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Karuna Therapeutics Inc Insider Transactions
Heather Preston Mailing Address
Above is the net worth, insider trading, and ownership report for Heather Preston. You might contact Heather Preston via mailing address: C/o Tpg Global, Llc, 301 Commerce Street, Fort Worth Tx 76102.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
